Proceedings: Effects of sodium, ouabain and DMPP on the neuronal efflux of noradrenaline.
D000818:Animals; D001369:Axons / Q000378:metabolism; D002118:Calcium / Q000378:metabolism; D004246:Dimethylphenylpiperazinium Iodide / Q000494:pharmacology; D005731:Ganglionic Stimulants / Q000494:pharmacology*; D066298:In Vitro Techniques; D009206:Myocardium / Q000378:metabolism; D009474:Neurons / Q000378:metabolism*; D009638:Norepinephrine / Q000378:metabolism*; D010042:Ouabain / Q000494:pharmacology*; D010293:Pargyline / Q000494:pharmacology; D010477:Perfusion; D010879:Piperazines / Q000494:pharmacology*; D011817:Rabbits; D012110:Reserpine / Q000494:pharmacology; D012964:Sodium / Q000494:pharmacology*; D013564:Sympathetic Nervous System / Q000378:metabolism
D005731:Ganglionic Stimulants; D010879:Piperazines; D004246:Dimethylphenylpiperazinium Iodide; D010042:Ouabain; D012110:Reserpine; D010293:Pargyline; D012964:Sodium; D002118:Calcium; D009638:Norepinephrine